ArticleContemporary clinical trials2026
Technology-enabled collaborative care management of depression in urban and rural cancer centers: Protocol and baseline results from the SCOPE pragmatic hybrid effectiveness-implementation trial.
Article in Contemporary clinical trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05012124 (Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers (AKA: SUPPORTING COLLABORATIVE CARE TO OPTIMIZE PSYCHOSOCIAL ENGAGEMENT IN THE CANCER SETTING [SCOPE])
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundUp to 25% of people with cancer will become clinically depressed. Unfortunately, most cancer patients with depression do not receive adequate treatment. The Collaborative Care Model (CoCM) is an evidence-based system of care that can lead to sustained improvement in depression symptoms and quality of life in patients with cancer, but high fidelity implementation has been slow. We previously used a human-centered design approach to design and develop a patient- and provider-facing web platform to enhance the implementation and fidelity of CoCM for depression in patients undergoing cancer treatment. We describe the methods and baseline characteristics for a trial that compares technology-enhanced CoCM to the current CoCM approach.
methodsThe technology-enhanced CoCM system (t-CoCM) will be compared to usual CoCM (u-CoCM) in a 9-month pragmatic hybrid effectiveness-implementation randomized controlled trial among patients receiving treatment for cancer at an NCI-designated comprehensive cancer center and a community cancer center. Outcomes include clinical outcomes and CoCM fidelity as well as implementation obstacles and opportunities.
resultsThe 297 patients randomized to the study (149 t-CoCM, 148 u-CoCM) represent a diverse sample with high medical and psychiatric comorbidity. 35% had breast cancer and 43% had metastatic disease. Mean (SD) baseline Hopkins Symptom Checklist-20 (1.9 [0.7]) and Patient Health Questionnaire-9 (15.3 [4.0]) depression scores indicate significant depression symptomatology.
conclusionsThe study will provide valuable practice-based information on processes and outcomes of CoCM for depression in patients receiving acute cancer treatment and on implementation of a web platform to enhance delivery of CoCM in this setting.
trial registrationClinicaltrials.gov identifier: NCT05012124 (submitted 8/11/21).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.